Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Clancy JP"'
Autor:
Zemanick, Edith T., Konstan, Michael W., VanDevanter, Donald R., Rowe, Steven M., Clancy, JP, Odem-Davis, Katherine, Skalland, Michelle, Mayer-Hamblett, Nicole
Publikováno v:
In Journal of Cystic Fibrosis November 2021 20(6):965-971
Autor:
Muhlebach, Marianne S., Clancy, JP, Heltshe, Sonya L., Ziady, Assem, Kelley, Tom, Accurso, Frank, Pilewski, Joseph, Mayer-Hamblett, Nicole, Joseloff, Elizabeth, Sagel, Scott D.
Publikováno v:
In Journal of Cystic Fibrosis November 2016 15(6):714-723
Autor:
Bilton D, Pressler T, Fajac I, Clancy JP, Sands D, Minic P, Cipolli M, Galeva I, Solé A, Quittner AL, Liu K, McGinnis JP, Eagle G, Gupta R, Konstan MW, CLEAR-108 Study Group
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Shortcomings of inhaled antibiotic treatments for Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF) include poor drug penetration, inactivation by sputum, poor efficiency due to protective biofilm, and short residence in the lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8da74bfa8256fa0e7eda853acbd76c45
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11033
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11033
Autor:
Tiddens HA, De Boeck K, Clancy JP, Fayon M, H. G. M. A, Bresnik M, Derchak A, Lewis SA, Oermann CM, ALPINE study investigators, RAIA, VALERIA
Publikováno v:
Journal of Cystic Fibrosis, 14(1), 111-119. Elsevier
Background: Consensus guidelines recommend early treatment to eradicate newly acquired Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) patients although there is no single preferred regimen. Aztreonam for inhalation solution (AZLI) sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e3eca6c26d22b3a1cf5c0eae82e6ca3
https://doi.org/10.1016/j.jcf.2014.06.003
https://doi.org/10.1016/j.jcf.2014.06.003
Autor:
Clancy, JP, Johnson, SG, Yee, SW, McDonagh, EM, Caudle, KE, Klein, TE, Cannavo, M, Giacomini, KM, Clinical Pharmacogenetics Implementation Consortium
Publikováno v:
Clinical pharmacology and therapeutics, vol 95, iss 6
Cystic fibrosis (CF) is a life-shortening disease arising as a consequence of mutations within the CFTR gene. Novel therapeutics for CF are emerging that target CF transmembrane conductance regulator protein (CFTR) defects resulting from specific CFT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::c7753459d75a2b5c18b03ebab1164efe
https://escholarship.org/uc/item/48r4255k
https://escholarship.org/uc/item/48r4255k
Autor:
Clancy Jp, McPhail Gl
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 49(4)
Cystic fibrosis (CF) is a life-shortening disorder that affects over 30,000 people in the U.S. and 70,000 worldwide. CF is caused by mutations in the CFTR gene, which codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79974759b948e91a259203e136ca106f
https://pubmed.ncbi.nlm.nih.gov/23616952
https://pubmed.ncbi.nlm.nih.gov/23616952
Autor:
Clancy, JP, Benitez, Debbie S., Fajac, Isabelle, Jain, Manu, Rowe, Steven M., Sawicki, Gregory
Publikováno v:
In Journal of Cystic Fibrosis May 2017 16(3):e9-e10
Autor:
Bebok, Zsuzsa, Collawn, James F, Wakefield, John, Parker, William, Li, Yao, Varga, Karoly, Sorscher, Eric J, Clancy, JP
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cyclic AMP-regulated chloride channel. Mutations in the CFTR gene result in cystic fibrosis (CF). The most common mutation, deltaF508, results in endoplasmic reticulum-associated deg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f9385462ca9736d8002a7a89fdbb799
https://europepmc.org/articles/PMC1464253/
https://europepmc.org/articles/PMC1464253/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.